In the first quarter of 2019, NuVasive reported a 5.5 percent increase in revenue.
Four things to know:
1. First quarter revenue hit $274.8 million, a 5.5 percent increase year over year. Gross profit hit $200.3 million and reported GAAP net income was $9.4 million.
2. NuVasive estimates full year revenue will hit $1.14 billion to $1.16 billion, which will be a 3.5 percent to 5.5 percent increase year over year. By year's end, the company expects a 25.2 percent to 25.7 percent EBITDA margin.
3. During the first quarter, the company launched the X360 System for lateral single-position surgery with integrated surgical intelligence technology. The company soon expects to launch the Pulse platform, a robotics platform for spinal procedures.
4. In April, the Journal of Spine & Neurosurgery published an article comparing the outcomes of porous PEEK, smooth PEEK and structural allograft interbody devices for anterior cervical discectomy and fusion. The study concluded NuVasive's proprietary Cohere Porous PEEK implant demonstrated benefit over the structural allograft and smooth PEEK devices.